Skip Nav Destination
1-20 of 30
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Prothrombin Complex Concentrates (PCCs) Have Limited Effect on TF-Initiated Thrombin Generation in FXa Inhibitor-Anticoagulated Plasma: In Vitro Comparison between Direct Reversal By Andexanet Alfa and "Work Around" By PCCs
Blood (2019) 134 (Supplement_1): 713.
A Rise in Plasma Coagulability during the First 3 Months Following Provoked Venous Thromboembolism Is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank
Marisol Betensky, MDMPH, Ernest Amankwah, PhD, Stephanie Brandal, Allen Everett, MD, Neil A Goldenberg, MD PhD
Blood (2019) 134 (Supplement_1): 2424.
Rebound Hypercoagulability Following a Conventional Course of Anticoagulation and the Risk of Recurrent Venous Thromboembolism in Young Patients: First Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank
Blood (2017) 130 (Supplement 1): 556.
A Novel Laboratory Assay for Monitoring Unfractionated Heparin in Patients Taking Direct Oral Anticoagulants Prior to Hospital Admission
Sydney Strickland, PhD BS, Surabhi Palkimas, PharmD, Julianne Fallon, MD, Thomas Schultz, PharmD, Rebecca Hockman, Mary Acker, Lindsay Bazydlo, PhD
Blood (2017) 130 (Supplement 1): 3721.
The Use of Thromboelastography in Monitoring Coagulation Status for Patients Treated with Low Molecular Weight Heparin, Warfarin, Apixaban, and Rivaroxaban
Debbie Jiang, MD, Anne Dumont, RN, Adrienne J. Burns, MMS, PA-C, Henry Rinder, MD, Christopher A. Tormey, MD, Alfred Lee, MD PhD
Blood (2017) 130 (Supplement 1): 3741.
Natalie H Wallace, MD MPH, Anne Dumont, BS, Adrienne Burns, PA, Tormey A Christopher, MD, Henry M Rinder, MD, Martin A Kriegel, MD PhD, Lenore M Buckley, MD MPH, Doruk Erkan, MD MPH, Alfred I Lee, MD PhD
Blood (2016) 128 (22): 4983.
Blood (2012) 120 (21): 3952.
Jawed Fareed, PhD, Debra Hoppensteadt, Ph.D., Albara Ottman, Omer Iqbal, MD, Walter Jeske, Ph.D., Angel Gray, Jeanine M. Walenga, PhD, Evi Kalodiki, PhD, Indermohan Thethi, MD, Rakesh Wahi, MD
Blood (2011) 118 (21): 1249.
Molecular Mimicry in the Adulteration of Heparins. Chemical Basis for the Development of Oversulfated Chondroitin Sulfate and Related Contaminants
Jawed Fareed, PhD, Rakesh Wahi, MD, Indermohan Thethi, MD, Debra Hoppensteadt, Ph.D., Vinod Bansal, MD, Jeanine M. Walenga, PhD, Harry L. Messmore, MD
Blood (2011) 118 (21): 4322.
Debra Hoppensteadt, Ph.D., Angel Gray, Josephine Cunanan, MD, Walter Jeske, Ph.D., Jeanine M. Walenga, PhD, Jawed Fareed, PhD
Blood (2010) 116 (21): 4394.
Jawed Fareed, Eduardo Ramacciotti, Debra Hoppensteadt, Nasir Sadeghi, Arif Hussain, David VanThiel, Magdalena George
Blood (2009) 114 (22): 1070.
HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium
Chiara Urbinati, Stefania Nicoli, Mauro Giacca, Guido David, Simona Fiorentini, Arnaldo Caruso, Massimo Alfano, Luca Cassetta, Marco Presta, Marco Rusnati
Blood (2009) 114 (15): 3335–3342.
Includes: Supplemental data
Effects of Angiotensin-Converting Enzyme Inhibition on Thromboelastogaphy for Infants and Children Presenting for Elective Cardiac Surgery.
Michael L Schmitz, MD, Edgar D St. Amour, M.Sc., Kimo Stine, MD, Mark A Austen, MS, Chanhee Jo, PhD, Pamela Killebrew, RNP, Robert J Jaquiss, MD
Blood (2008) 112 (11): 1225.
Molecular and Functional Heterogeneity in Contaminants Isolated from Recalled Heparin. Impact on Anticoagulation and Potential Adverse Reactions
Jawed Fareed, Ph.D., Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Cafer Adiguzel, MD, Omer Iqbal, MD, Jeanine M. Walenga, PhD
Blood (2008) 112 (11): 4048.
Recombinant Factor VIIa Combined with Fibrinogen Corrects the Coagulopathy Associated with Cardiopulmonary Bypass Surgery Ex Vivo
Pall T. Onundarson, M.D., Hanna S. Asvaldsdottir, M.Sc., Brynja R. Gudmundsdottir, M.Sc., Benny Sorensen, M.D., Ph.D.
Blood (2008) 112 (11): 4097.
Compositional Differences in the Oligosaccharide Components of Generic Versions of Enoxaparin and Dalteparin.
Walter P. Jeske, PhD, Aleah Brubaker, B.S., Debra Hoppensteadt, Ph.D., Jeanine M. Walenga, Ph.D., Qing Ma, Ph.D., Jawed Fareed, Ph.D.
Blood (2007) 110 (11): 3999.
Blood (2007) 110 (11): 2160.5.
AVE5026: A Novel, Extractive Heparinoid with Enriched Anti-Xa Activity and Enhanced Antithrombotic Activity.
Debra Hoppensteadt, PhD, Josephine Cunanan, M.D., Eric Geniaux, Ph.D., Martin Lorenz, Ph.D., Christian Viskov, Ph.D., Pascal Ythier-Moury, Ph.D., Jean-Francois Brin, M.D., Walter Jeske, Ph.D.
Blood (2007) 110 (11): 1881.
Blood (2007) 110 (11): 3951.
Blood (2006) 108 (11): 1054.